The Most Recent Trends of Peritoneal Dialysis in Japan

By 31 December 2006, more than 260 000 patients were on dialysis therapy in Japan, and 9243 of them (3.6%) were on peritoneal dialysis (PD). The mean age of PD patients was 5 years less than that of all patients with chronic kidney disease, and the prevalence of diabetes among them was 9.4% lower. Among the PD patients, 18.0% were being treated with a combination of PD and hemodialysis, and 33.4% were being treated with automated PD. A peritoneal equilibration test (PET) had been performed in 22.0% of the patients, who were then classified into the four PET categories. Of the tested patients, 10.3% were placed in the low (L) category; 38.3% in the low-average (LA) category; 38.4%, in the high-average (HA) category; and 13.0%, in the high (H) category. Icodextrin was used by 27.3% of patients classified L, 30.5% of those classified LA, 47.1% of those classified HA, and 55.1% of those classified H. The annual death rate was 6.1%, which was lower than the rate for HD (9.7%); and the annual withdrawal rate was 19.8%. Infectious complications were the main cause for lowered rates of patient and technique survival. Use of PD for older and diabetic patients and of combination therapy with hemodialysis are key perspectives in the most recent report on PD in Japan.

[1]  W. van Biesen,et al.  The Fate of Older Diabetic Patients on Peritoneal Dialysis: Myths and Mysteries and Suggestions for Further Research , 2007, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[2]  J. Bargman,et al.  Guideline on Targets for Solute and Fluid Removal in Adult Patients on Chronic Peritoneal Dialysis , 2006, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[3]  R. Selgas,et al.  European best practice guidelines for peritoneal dialysis. 7 Adequacy of peritoneal dialysis. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  D. Oreopoulos Peritoneal Dialysis in the Far East: An Awaking Giant , 2004, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[5]  Y. Kawaguchi,et al.  Encapsulating peritoneal sclerosis in Japan: a prospective, controlled, multicenter study. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  T. Chan,et al.  Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study. , 2003, Kidney international.

[7]  D. Churchill The ADEMEX Study: make haste slowly. , 2002, Journal of the American Society of Nephrology : JASN.

[8]  E. Vonesh,et al.  Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. , 2002, Journal of the American Society of Nephrology : JASN.

[9]  B. Stojimirović,et al.  Quality of Life of Elderly Patients Undergoing Continuous Ambulatory Peritoneal Dialysis , 2001, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[10]  T Ostbye,et al.  Predictors of loss of residual renal function among new dialysis patients. , 2000, Journal of the American Society of Nephrology : JASN.

[11]  J. Bargman,et al.  Guidelines for adequacy and nutrition in peritoneal dialysis. Canadian Society of Nephrology. , 1999, Journal of the American Society of Nephrology : JASN.

[12]  K. Th,et al.  CAPD, an acceptable form of therapy in elderly ESRD patients: a comparative study. , 1997 .

[13]  D. Cho,et al.  CAPD, an acceptable form of therapy in elderly ESRD patients: a comparative study. , 1997, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

[14]  Z. Twardowski Clinical value of standardized equilibration tests in CAPD patients. , 1989, Blood purification.